FR2525475B1 - Antigenes de la leucemie des cellules t de l'adulte, procedes pour leur preparation et pour le dosage d'anticorps contre ces antigenes - Google Patents

Antigenes de la leucemie des cellules t de l'adulte, procedes pour leur preparation et pour le dosage d'anticorps contre ces antigenes

Info

Publication number
FR2525475B1
FR2525475B1 FR8306843A FR8306843A FR2525475B1 FR 2525475 B1 FR2525475 B1 FR 2525475B1 FR 8306843 A FR8306843 A FR 8306843A FR 8306843 A FR8306843 A FR 8306843A FR 2525475 B1 FR2525475 B1 FR 2525475B1
Authority
FR
France
Prior art keywords
antigens
adult
assay
preparation
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8306843A
Other languages
English (en)
Other versions
FR2525475A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of FR2525475A1 publication Critical patent/FR2525475A1/fr
Application granted granted Critical
Publication of FR2525475B1 publication Critical patent/FR2525475B1/fr
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57426Specifically defined cancers leukemia
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
FR8306843A 1982-04-26 1983-04-26 Antigenes de la leucemie des cellules t de l'adulte, procedes pour leur preparation et pour le dosage d'anticorps contre ces antigenes Expired FR2525475B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57071080A JPS58187861A (ja) 1982-04-26 1982-04-26 成人型t細胞性白血病関連抗体の測定法

Publications (2)

Publication Number Publication Date
FR2525475A1 FR2525475A1 (fr) 1983-10-28
FR2525475B1 true FR2525475B1 (fr) 1985-10-31

Family

ID=13450182

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8306843A Expired FR2525475B1 (fr) 1982-04-26 1983-04-26 Antigenes de la leucemie des cellules t de l'adulte, procedes pour leur preparation et pour le dosage d'anticorps contre ces antigenes

Country Status (13)

Country Link
JP (1) JPS58187861A (fr)
BE (1) BE896571A (fr)
CA (1) CA1197776A (fr)
CH (1) CH652033A5 (fr)
DE (1) DE3315081A1 (fr)
DK (1) DK181883A (fr)
ES (1) ES8501530A1 (fr)
FR (1) FR2525475B1 (fr)
GB (1) GB2122343B (fr)
IT (1) IT1197633B (fr)
NL (1) NL8301464A (fr)
PH (1) PH19194A (fr)
SE (1) SE8302329L (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5962527A (ja) * 1982-09-30 1984-04-10 Eisai Co Ltd 成人t細胞白血病関連抗原の製造方法
JPS59151885A (ja) * 1983-02-18 1984-08-30 Eisai Co Ltd 成人t細胞白血病関連細胞株
US4743678A (en) * 1983-04-27 1988-05-10 President And Fellows Of Harvard College Method and products for detection of human T cell leukemia virus
JPS6044870A (ja) * 1983-08-22 1985-03-11 Fujirebio Inc 成人t細胞白血病ウイルス抗体検出用試薬
JPS60249058A (ja) * 1984-05-25 1985-12-09 Eisai Co Ltd Atlウイルス抗体の測定方法および試薬
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
US5614366A (en) * 1986-12-31 1997-03-25 Genelabs Technologies, Inc. HTLV-I peptide antigens and kit
JP2525054B2 (ja) * 1989-08-01 1996-08-14 株式会社トクヤマ 成人t細胞白血病ウィルス感染診断薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
AU527489B2 (en) * 1978-03-20 1983-03-10 Abbott Laboratories Sugar coated reagents for solid phase immunoassay
FR2435715A1 (fr) * 1979-01-31 1980-04-04 Sanyo Chemical Ind Ltd Nouveaux produits conjugues substance a activite immunologique-verre
CA1148859A (fr) * 1979-06-14 1983-06-28 Lacy R. Overby Technique pour le depistage simultane de deux virus de l'hepatite dans un milieu solide
DE3005495C2 (de) * 1980-02-14 1983-03-31 Institut Pasteur, 75724 Paris Herstellung von Fragmenten von Viren mit Lipidhülle und sie enthaltende Arzneimittelzubereitungen

Also Published As

Publication number Publication date
IT8348154A0 (it) 1983-04-26
NL8301464A (nl) 1983-11-16
CA1197776A (fr) 1985-12-10
DK181883A (da) 1983-10-27
IT1197633B (it) 1988-12-06
CH652033A5 (fr) 1985-10-31
FR2525475A1 (fr) 1983-10-28
ES522186A0 (es) 1984-12-01
JPH0143908B2 (fr) 1989-09-25
BE896571A (fr) 1983-10-26
JPS58187861A (ja) 1983-11-02
DK181883D0 (da) 1983-04-25
GB2122343A (en) 1984-01-11
PH19194A (en) 1986-01-28
GB2122343B (en) 1985-09-04
ES8501530A1 (es) 1984-12-01
SE8302329L (sv) 1983-10-27
SE8302329D0 (sv) 1983-04-25
GB8311373D0 (en) 1983-06-02
DE3315081A1 (de) 1983-11-03

Similar Documents

Publication Publication Date Title
FR2531956B1 (fr) Composes bicycliques, procede pour leur preparation et medicaments qui les contiennent
BE896986A (fr) Derives d'indole, procedes pour leur preparation et composition pharmaceutiques les contenant
IL76142A (en) Monoclonal antibody specific to a human carcinoma tumor-associated antigen kc-4,hybrid cell lines producing the same,pharmaceutical compositions containing them and methods for the use thereof
PT72631A (fr) Procede pour la preparations de nouveaux composes hetherocycliques et de compositions pharmaceutiques qui les contiennent
DE3366393D1 (en) Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same
BE846934A (fr) Composes d'azetidinone et procedes pour leur preparation,
NZ213293A (en) Monoclonal antibodies used to detect glycosphingo lipids associated with cancer cells
OA08444A (fr) Nouveaux céphèmes et procédés pour leur préparation.
FR2525475B1 (fr) Antigenes de la leucemie des cellules t de l'adulte, procedes pour leur preparation et pour le dosage d'anticorps contre ces antigenes
FR2574793B1 (fr) Composes derives d'indole, compositions pharmaceutiques les contenant et procede pour leur preparation
FR2534921B1 (fr) Composes amino heterocycliques et procedes pour leur preparation
FR2562071B1 (fr) Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant
BE885507A (fr) Composes heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2612373B1 (fr) Compositions dietetiques et procede pour leur preparation
IL77990A (en) Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same
BE885633A (fr) Derives de 1,2,4-oxadiazolin-5-one, procede pour leur preparation et compositions pharmaceutiques les contenant
BE889497A (fr) Aminocyclopentanone amides, leur preparation et compositions pharmaceutiques qui les contiennent
MC1549A1 (fr) Anthracycline-glycosides,procede pour leur preparation et medicaments les contenant
FR2513994B1 (fr) Tripeptides anorexigenes, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2549726B1 (fr) Facteurs augmentant la formation d'anticorps humains et procede pour leur preparation
FR2529549B1 (fr) Oxime-ethers d'eburnane, procede pour leur preparation et compositions pharmaceutiques qui les contiennent
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2551440B1 (fr) Aminocyclopentanes, leur procede de preparation et compositions pharmaceutiques les contenant
BE896628A (fr) Derives de cycloalcanes, procede pour leur preparation et compositions les contenant.
FR2528829B1 (fr) Composes polyprenyliques, procedes pour leur preparation et composition therapeutique les contenant

Legal Events

Date Code Title Description
TP Transmission of property